DNA Capital
Overview
DNA Capital is a global healthcare investment firm that partners with early to late-stage companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| ZaiNar | Sep 2021 | Series A | Co-investor |
| Beep Saúde | Nov 2022 | Series C | Co-investor |
| Sanar | Mar 2025 | Early Funding | Co-investor |
| Reema Health | Oct 2024 | Series A | Co-investor |
| Galileo | Feb 2022 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
José Eduardo Ribeiro Guinle
Partner
Partha Mishra
Partner
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is DNA Capital based?
DNA Capital is headquartered in São Paulo, Brazil.
When was DNA Capital founded?
DNA Capital was founded in 2013.
How many portfolio companies does DNA Capital have?
DNA Capital has 15 portfolio companies in Caplight's dataset.
What are some companies in DNA Capital's portfolio?
Portfolio companies visible on Caplight include ZaiNar, Beep Saúde, Sanar, Reema Health, Galileo.
What was DNA Capital's most recent investment shown here?
DNA Capital's most recent investment in this portfolio sample was in Sanar in 2025.
What sectors does DNA Capital focus on?
DNA Capital focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, Healthcare & Life Sciences, Healthcare & Life Sciences, FinTech, AI, Data & Cloud Infrastructure, Consumer & Commerce, AI, Data & Cloud Infrastructure, Telecommunications & Networking, AI, Data & Cloud Infrastructure, Enterprise Software, Healthcare & Life Sciences, Enterprise Software, Enterprise Software, Healthcare & Life Sciences, Mobility, Transportation & Logistics, AI, Data & Cloud Infrastructure, Enterprise Software, Consumer & Commerce, Consumer & Commerce.
What company stages does DNA Capital focus on?
DNA Capital typically invests at the Early stage.
What is DNA Capital's AUM?
DNA Capital's assets under management are estimated between $100.0M and $250.0M.